A synergistic approach to combatting lung cancer

Genprex’s novel immunogene therapy encapsulates cancer-fighting genes into nanoscale spheres for delivery into cancer cells to interrupt cell replication and proliferation and induce programmed cell death. Used in combination with targeted therapies and immunotherapies, this investigational gene therapy is intended to help overcome tumor resistance to treatment, improve clinical responses, and expand the pool of patients who may benefit from promising anti-cancer therapies.